Stephen Robb

The Diagnostic Accuracy of Plasma BNP and NTproBNP in Patients Referred From Primary Care with sUspected Heart Failure: Results of the UK Natriuretic Peptide Study

Alex Zaphiriou, Stephen Robb, Tarita Murray‐Thomas et al. · European Journal of Heart Failure · 2005 · 318 citations

Medicine, Cardiology, Internal Medicine +12

Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

Jean‐Claude Tardif, Jean-François Tanguay, Scott Wright et al. · Journal of the American College of Cardiology · 2013 · 208 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Index of Microcirculatory Resistance Measured Acutely Predicts the Extent and Severity of Myocardial Infarction in Patients With ST-Segment Elevation Myocardial Infarction

Ross McGeoch, Stuart Watkins, Colin Berry et al. · JACC: Cardiovascular Interventions · 2010 · 189 citations

Medicine, Cardiology, Internal Medicine +14

Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population

Olav Wendelboe Nielsen, Theresa A. McDonagh, Stephen Robb et al. · Journal of the American College of Cardiology · 2002 · 145 citations

Medicine, Cardiology, Internal Medicine +8

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial

Barbara E. Stähli, Cathérine Gebhard, Valérie Duchatelle et al. · Journal of the American Heart Association · 2016 · 78 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17